Strata Critical Medical (SRTA) Return on Invested Capital (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2023 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital rose to 0.0% in Q1 2026 per SRTA's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q1 2026 and bottomed at 0.0% in Q3 2024.
• The 5-year median for Return on Invested Capital is 0.0% (2023), against an average of 0.0%.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2023, while the deepest fall reached 0 bps in 2023.
• Tracing SRTA's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then tumbled by 122 bps to 0.0% in 2023, then surged by 42 bps to 0.0% in 2024, then jumped by 47 bps to 0.0% in 2025, then gained by 12 bps to 0.0% in 2026.
• Per Business Quant, the three latest SRTA Return on Invested Capital figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison